CRH Medical Corporation (NYSEAMERICAN:CRHM)’s earnings report is expected on March, 13 after the close., according to RTT. Analysts forecast $0.02 earnings per share, which is $0.02 down or 50.00 % from 2018’s $0.04 earnings per share. If the current earnings per share of $0.02 is accurate, CRHM’s profit could hit $1.42M. CRHM is touching $3.08 during the last trading session, after decreased 0.65%.Currently CRH Medical Corporation is uptrending after 10.00% change in last March 5, 2018. CRHM has also 28,635 shares volume. CRHM outperformed the S&P500 by 5.63%.

CRH Medical Corporation provides products and services to physicians for the treatment of gastrointestinal diseases in the United States.The firm is valued at $219.24 million. It offers anesthesia services for patients undergoing endoscopic procedures; and CRH O'Regan System, a single use, disposable, and hemorrhoid banding technology for treating hemorrhoid grades I??IV.The P/E ratio is 36.24. The firm distributes the CRH O'Regan System, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians.

Another two news for CRH Medical Corporation (NYSEAMERICAN:CRHM) were briefly posted by: Investorplace.com on June 19, 2018 with title “4 Undervalued MedTech Stocks to Consider Amid Volatility – Investorplace.com”. The other Prnewswire.com‘s article was titled “CRH Medical Receives TSX Approval for Renewal of Normal Course Issuer Bid – PR Newswire” and posted on November 05, 2018.